[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Placental Stem Cell Therapy Market Insights, Forecast to 2029

December 2023 | 91 pages | ID: GCBD30E64D9EEN
QYResearch

US$ 4,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report presents an overview of global market for Placental Stem Cell Therapy market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Placental Stem Cell Therapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Placental Stem Cell Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Placental Stem Cell Therapy revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Placental Stem Cell Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Placental Stem Cell Therapy revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Lifebank Stem Cell Banking, Cynata, Celularity, Athersys, Americord Registry, ReNeuron Group, ReeLabs, Mesoblast and Pluristem Therapeutics, etc.

By Company
  • Lifebank Stem Cell Banking
  • Cynata
  • Celularity
  • Athersys
  • Americord Registry
  • ReNeuron Group
  • ReeLabs
  • Mesoblast
  • Pluristem Therapeutics
Segment by Type
  • Hematologic Malignancies and Disorders
  • Congenital Immunodeficiency Disorders
  • Metabolic Disorders
  • Neurological Disorders
  • Others
Segment by Application
  • Hospitals and Specialty Clinics
  • Clinical Research Organizations
  • Research Institutes and Academies
  • Others
By Region
  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East, Africa, and Latin America
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA
Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Placental Stem Cell Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Placental Stem Cell Therapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America by type, by application and by country, revenue for each segment.

Chapter 7: Europe by type, by application and by country, revenue for each segment.

Chapter 8: China by type and by application revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Placental Stem Cell Therapy revenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Market Analysis by Type
  1.2.1 Global Placental Stem Cell Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
  1.2.2 Hematologic Malignancies and Disorders
  1.2.3 Congenital Immunodeficiency Disorders
  1.2.4 Metabolic Disorders
  1.2.5 Neurological Disorders
  1.2.6 Others
1.3 Market by Application
  1.3.1 Global Placental Stem Cell Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
  1.3.2 Hospitals and Specialty Clinics
  1.3.3 Clinical Research Organizations
  1.3.4 Research Institutes and Academies
  1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Placental Stem Cell Therapy Market Perspective (2018-2029)
2.2 Global Placental Stem Cell Therapy Growth Trends by Region
  2.2.1 Placental Stem Cell Therapy Market Size by Region: 2018 VS 2022 VS 2029
  2.2.2 Placental Stem Cell Therapy Historic Market Size by Region (2018-2023)
  2.2.3 Placental Stem Cell Therapy Forecasted Market Size by Region (2024-2029)
2.3 Placental Stem Cell Therapy Market Dynamics
  2.3.1 Placental Stem Cell Therapy Industry Trends
  2.3.2 Placental Stem Cell Therapy Market Drivers
  2.3.3 Placental Stem Cell Therapy Market Challenges
  2.3.4 Placental Stem Cell Therapy Market Restraints

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Revenue Placental Stem Cell Therapy by Players
  3.1.1 Global Placental Stem Cell Therapy Revenue by Players (2018-2023)
  3.1.2 Global Placental Stem Cell Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Placental Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Placental Stem Cell Therapy, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Placental Stem Cell Therapy Market Concentration Ratio
  3.4.1 Global Placental Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
  3.4.2 Global Top 10 and Top 5 Companies by Placental Stem Cell Therapy Revenue in 2022
3.5 Global Key Players of Placental Stem Cell Therapy Head office and Area Served
3.6 Global Key Players of Placental Stem Cell Therapy, Product and Application
3.7 Global Key Players of Placental Stem Cell Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans

4 PLACENTAL STEM CELL THERAPY BREAKDOWN DATA BY TYPE

4.1 Global Placental Stem Cell Therapy Historic Market Size by Type (2018-2023)
4.2 Global Placental Stem Cell Therapy Forecasted Market Size by Type (2024-2029)

5 PLACENTAL STEM CELL THERAPY BREAKDOWN DATA BY APPLICATION

5.1 Global Placental Stem Cell Therapy Historic Market Size by Application (2018-2023)
5.2 Global Placental Stem Cell Therapy Forecasted Market Size by Application (2024-2029)

6 NORTH AMERICA

6.1 North America Placental Stem Cell Therapy Market Size (2018-2029)
6.2 North America Placental Stem Cell Therapy Market Size by Type
  6.2.1 North America Placental Stem Cell Therapy Market Size by Type (2018-2023)
  6.2.2 North America Placental Stem Cell Therapy Market Size by Type (2024-2029)
  6.2.3 North America Placental Stem Cell Therapy Market Share by Type (2018-2029)
6.3 North America Placental Stem Cell Therapy Market Size by Application
  6.3.1 North America Placental Stem Cell Therapy Market Size by Application (2018-2023)
  6.3.2 North America Placental Stem Cell Therapy Market Size by Application (2024-2029)
  6.3.3 North America Placental Stem Cell Therapy Market Share by Application (2018-2029)
6.4 North America Placental Stem Cell Therapy Market Size by Country
  6.4.1 North America Placental Stem Cell Therapy Market Size by Country: 2018 VS 2022 VS 2029
  6.4.2 North America Placental Stem Cell Therapy Market Size by Country (2018-2023)
  6.4.3 North America Placental Stem Cell Therapy Market Size by Country (2024-2029)
  6.4.4 United States
  6.4.5 Canada

7 EUROPE

7.1 Europe Placental Stem Cell Therapy Market Size (2018-2029)
7.2 Europe Placental Stem Cell Therapy Market Size by Type
  7.2.1 Europe Placental Stem Cell Therapy Market Size by Type (2018-2023)
  7.2.2 Europe Placental Stem Cell Therapy Market Size by Type (2024-2029)
  7.2.3 Europe Placental Stem Cell Therapy Market Share by Type (2018-2029)
7.3 Europe Placental Stem Cell Therapy Market Size by Application
  7.3.1 Europe Placental Stem Cell Therapy Market Size by Application (2018-2023)
  7.3.2 Europe Placental Stem Cell Therapy Market Size by Application (2024-2029)
  7.3.3 Europe Placental Stem Cell Therapy Market Share by Application (2018-2029)
7.4 Europe Placental Stem Cell Therapy Market Size by Country
  7.4.1 Europe Placental Stem Cell Therapy Market Size by Country: 2018 VS 2022 VS 2029
  7.4.2 Europe Placental Stem Cell Therapy Market Size by Country (2018-2023)
  7.4.3 Europe Placental Stem Cell Therapy Market Size by Country (2024-2029)
  7.4.3 Germany
  7.4.4 France
  7.4.5 U.K.
  7.4.6 Italy
  7.4.7 Russia
  7.4.8 Nordic Countries

8 CHINA

8.1 China Placental Stem Cell Therapy Market Size (2018-2029)
8.2 China Placental Stem Cell Therapy Market Size by Type
  8.2.1 China Placental Stem Cell Therapy Market Size by Type (2018-2023)
  8.2.2 China Placental Stem Cell Therapy Market Size by Type (2024-2029)
  8.2.3 China Placental Stem Cell Therapy Market Share by Type (2018-2029)
8.3 China Placental Stem Cell Therapy Market Size by Application
  8.3.1 China Placental Stem Cell Therapy Market Size by Application (2018-2023)
  8.3.2 China Placental Stem Cell Therapy Market Size by Application (2024-2029)
  8.3.3 China Placental Stem Cell Therapy Market Share by Application (2018-2029)

9 ASIA (EXCLUDING CHINA)

9.1 Asia Placental Stem Cell Therapy Market Size (2018-2029)
9.2 Asia Placental Stem Cell Therapy Market Size by Type
  9.2.1 Asia Placental Stem Cell Therapy Market Size by Type (2018-2023)
  9.2.2 Asia Placental Stem Cell Therapy Market Size by Type (2024-2029)
  9.2.3 Asia Placental Stem Cell Therapy Market Share by Type (2018-2029)
9.3 Asia Placental Stem Cell Therapy Market Size by Application
  9.3.1 Asia Placental Stem Cell Therapy Market Size by Application (2018-2023)
  9.3.2 Asia Placental Stem Cell Therapy Market Size by Application (2024-2029)
  9.3.3 Asia Placental Stem Cell Therapy Market Share by Application (2018-2029)
9.4 Asia Placental Stem Cell Therapy Market Size by Region
  9.4.1 Asia Placental Stem Cell Therapy Market Size by Region: 2018 VS 2022 VS 2029
  9.4.2 Asia Placental Stem Cell Therapy Market Size by Region (2018-2023)
  9.4.3 Asia Placental Stem Cell Therapy Market Size by Region (2024-2029)
  9.4.4 Japan
  9.4.5 South Korea
  9.4.6 China Taiwan
  9.4.7 Southeast Asia
  9.4.8 India
  9.4.9 Australia

10 MIDDLE EAST, AFRICA, AND LATIN AMERICA

10.1 Middle East, Africa, and Latin America Placental Stem Cell Therapy Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Placental Stem Cell Therapy Market Size by Type
  10.2.1 Middle East, Africa, and Latin America Placental Stem Cell Therapy Market Size by Type (2018-2023)
  10.2.2 Middle East, Africa, and Latin America Placental Stem Cell Therapy Market Size by Type (2024-2029)
  10.2.3 Middle East, Africa, and Latin America Placental Stem Cell Therapy Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Placental Stem Cell Therapy Market Size by Application
  10.3.1 Middle East, Africa, and Latin America Placental Stem Cell Therapy Market Size by Application (2018-2023)
  10.3.2 Middle East, Africa, and Latin America Placental Stem Cell Therapy Market Size by Application (2024-2029)
  10.3.3 Middle East, Africa, and Latin America Placental Stem Cell Therapy Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Placental Stem Cell Therapy Market Size by Country
  10.4.1 Middle East, Africa, and Latin America Placental Stem Cell Therapy Market Size by Country: 2018 VS 2022 VS 2029
  10.4.2 Middle East, Africa, and Latin America Placental Stem Cell Therapy Market Size by Country (2018-2023)
  10.4.3 Middle East, Africa, and Latin America Placental Stem Cell Therapy Market Size by Country (2024-2029)
  10.4.4 Brazil
  10.4.5 Mexico
  10.4.6 Turkey
  10.4.7 Saudi Arabia
  10.4.8 Israel
  10.4.9 GCC Countries

11 KEY PLAYERS PROFILES

11.1 Lifebank Stem Cell Banking
  11.1.1 Lifebank Stem Cell Banking Company Details
  11.1.2 Lifebank Stem Cell Banking Business Overview
  11.1.3 Lifebank Stem Cell Banking Placental Stem Cell Therapy Introduction
  11.1.4 Lifebank Stem Cell Banking Revenue in Placental Stem Cell Therapy Business (2018-2023)
  11.1.5 Lifebank Stem Cell Banking Recent Developments
11.2 Cynata
  11.2.1 Cynata Company Details
  11.2.2 Cynata Business Overview
  11.2.3 Cynata Placental Stem Cell Therapy Introduction
  11.2.4 Cynata Revenue in Placental Stem Cell Therapy Business (2018-2023)
  11.2.5 Cynata Recent Developments
11.3 Celularity
  11.3.1 Celularity Company Details
  11.3.2 Celularity Business Overview
  11.3.3 Celularity Placental Stem Cell Therapy Introduction
  11.3.4 Celularity Revenue in Placental Stem Cell Therapy Business (2018-2023)
  11.3.5 Celularity Recent Developments
11.4 Athersys
  11.4.1 Athersys Company Details
  11.4.2 Athersys Business Overview
  11.4.3 Athersys Placental Stem Cell Therapy Introduction
  11.4.4 Athersys Revenue in Placental Stem Cell Therapy Business (2018-2023)
  11.4.5 Athersys Recent Developments
11.5 Americord Registry
  11.5.1 Americord Registry Company Details
  11.5.2 Americord Registry Business Overview
  11.5.3 Americord Registry Placental Stem Cell Therapy Introduction
  11.5.4 Americord Registry Revenue in Placental Stem Cell Therapy Business (2018-2023)
  11.5.5 Americord Registry Recent Developments
11.6 ReNeuron Group
  11.6.1 ReNeuron Group Company Details
  11.6.2 ReNeuron Group Business Overview
  11.6.3 ReNeuron Group Placental Stem Cell Therapy Introduction
  11.6.4 ReNeuron Group Revenue in Placental Stem Cell Therapy Business (2018-2023)
  11.6.5 ReNeuron Group Recent Developments
11.7 ReeLabs
  11.7.1 ReeLabs Company Details
  11.7.2 ReeLabs Business Overview
  11.7.3 ReeLabs Placental Stem Cell Therapy Introduction
  11.7.4 ReeLabs Revenue in Placental Stem Cell Therapy Business (2018-2023)
  11.7.5 ReeLabs Recent Developments
11.8 Mesoblast
  11.8.1 Mesoblast Company Details
  11.8.2 Mesoblast Business Overview
  11.8.3 Mesoblast Placental Stem Cell Therapy Introduction
  11.8.4 Mesoblast Revenue in Placental Stem Cell Therapy Business (2018-2023)
  11.8.5 Mesoblast Recent Developments
11.9 Pluristem Therapeutics
  11.9.1 Pluristem Therapeutics Company Details
  11.9.2 Pluristem Therapeutics Business Overview
  11.9.3 Pluristem Therapeutics Placental Stem Cell Therapy Introduction
  11.9.4 Pluristem Therapeutics Revenue in Placental Stem Cell Therapy Business (2018-2023)
  11.9.5 Pluristem Therapeutics Recent Developments

12 ANALYST'S VIEWPOINTS/CONCLUSIONS

13 APPENDIX

13.1 Research Methodology
  13.1.1 Methodology/Research Approach
  13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES

Table 1. Global Placental Stem Cell Therapy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Hematologic Malignancies and Disorders
Table 3. Key Players of Congenital Immunodeficiency Disorders
Table 4. Key Players of Metabolic Disorders
Table 5. Key Players of Neurological Disorders
Table 6. Key Players of Others
Table 7. Global Placental Stem Cell Therapy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 8. Global Placental Stem Cell Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Placental Stem Cell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Placental Stem Cell Therapy Market Share by Region (2018-2023)
Table 11. Global Placental Stem Cell Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Placental Stem Cell Therapy Market Share by Region (2024-2029)
Table 13. Placental Stem Cell Therapy Market Trends
Table 14. Placental Stem Cell Therapy Market Drivers
Table 15. Placental Stem Cell Therapy Market Challenges
Table 16. Placental Stem Cell Therapy Market Restraints
Table 17. Global Placental Stem Cell Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Placental Stem Cell Therapy Revenue Share by Players (2018-2023)
Table 19. Global Top Placental Stem Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Placental Stem Cell Therapy as of 2022)
Table 20. Global Placental Stem Cell Therapy Industry Ranking 2021 VS 2022 VS 2023
Table 21. Global 5 Largest Players Market Share by Placental Stem Cell Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of Placental Stem Cell Therapy, Headquarters and Area Served
Table 23. Global Key Players of Placental Stem Cell Therapy, Product and Application
Table 24. Global Key Players of Placental Stem Cell Therapy, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Placental Stem Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Placental Stem Cell Therapy Revenue Market Share by Type (2018-2023)
Table 28. Global Placental Stem Cell Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Placental Stem Cell Therapy Revenue Market Share by Type (2024-2029)
Table 30. Global Placental Stem Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Placental Stem Cell Therapy Revenue Share by Application (2018-2023)
Table 32. Global Placental Stem Cell Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Placental Stem Cell Therapy Revenue Share by Application (2024-2029)
Table 34. North America Placental Stem Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America Placental Stem Cell Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 36. North America Placental Stem Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 37. North America Placental Stem Cell Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 38. North America Placental Stem Cell Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. North America Placental Stem Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Placental Stem Cell Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 41. Europe Placental Stem Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe Placental Stem Cell Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 43. Europe Placental Stem Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 44. Europe Placental Stem Cell Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 45. Europe Placental Stem Cell Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Europe Placental Stem Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe Placental Stem Cell Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 48. China Placental Stem Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 49. China Placental Stem Cell Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 50. China Placental Stem Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 51. China Placental Stem Cell Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 52. Asia Placental Stem Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia Placental Stem Cell Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 54. Asia Placental Stem Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 55. Asia Placental Stem Cell Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 56. Asia Placental Stem Cell Therapy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 57. Asia Placental Stem Cell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia Placental Stem Cell Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Placental Stem Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Placental Stem Cell Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Placental Stem Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Placental Stem Cell Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Placental Stem Cell Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 64. Middle East, Africa, and Latin America Placental Stem Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Placental Stem Cell Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 66. Lifebank Stem Cell Banking Company Details
Table 67. Lifebank Stem Cell Banking Business Overview
Table 68. Lifebank Stem Cell Banking Placental Stem Cell Therapy Product
Table 69. Lifebank Stem Cell Banking Revenue in Placental Stem Cell Therapy Business (2018-2023) & (US$ Million)
Table 70. Lifebank Stem Cell Banking Recent Developments
Table 71. Cynata Company Details
Table 72. Cynata Business Overview
Table 73. Cynata Placental Stem Cell Therapy Product
Table 74. Cynata Revenue in Placental Stem Cell Therapy Business (2018-2023) & (US$ Million)
Table 75. Cynata Recent Developments
Table 76. Celularity Company Details
Table 77. Celularity Business Overview
Table 78. Celularity Placental Stem Cell Therapy Product
Table 79. Celularity Revenue in Placental Stem Cell Therapy Business (2018-2023) & (US$ Million)
Table 80. Celularity Recent Developments
Table 81. Athersys Company Details
Table 82. Athersys Business Overview
Table 83. Athersys Placental Stem Cell Therapy Product
Table 84. Athersys Revenue in Placental Stem Cell Therapy Business (2018-2023) & (US$ Million)
Table 85. Athersys Recent Developments
Table 86. Americord Registry Company Details
Table 87. Americord Registry Business Overview
Table 88. Americord Registry Placental Stem Cell Therapy Product
Table 89. Americord Registry Revenue in Placental Stem Cell Therapy Business (2018-2023) & (US$ Million)
Table 90. Americord Registry Recent Developments
Table 91. ReNeuron Group Company Details
Table 92. ReNeuron Group Business Overview
Table 93. ReNeuron Group Placental Stem Cell Therapy Product
Table 94. ReNeuron Group Revenue in Placental Stem Cell Therapy Business (2018-2023) & (US$ Million)
Table 95. ReNeuron Group Recent Developments
Table 96. ReeLabs Company Details
Table 97. ReeLabs Business Overview
Table 98. ReeLabs Placental Stem Cell Therapy Product
Table 99. ReeLabs Revenue in Placental Stem Cell Therapy Business (2018-2023) & (US$ Million)
Table 100. ReeLabs Recent Developments
Table 101. Mesoblast Company Details
Table 102. Mesoblast Business Overview
Table 103. Mesoblast Placental Stem Cell Therapy Product
Table 104. Mesoblast Revenue in Placental Stem Cell Therapy Business (2018-2023) & (US$ Million)
Table 105. Mesoblast Recent Developments
Table 106. Pluristem Therapeutics Company Details
Table 107. Pluristem Therapeutics Business Overview
Table 108. Pluristem Therapeutics Placental Stem Cell Therapy Product
Table 109. Pluristem Therapeutics Revenue in Placental Stem Cell Therapy Business (2018-2023) & (US$ Million)
Table 110. Pluristem Therapeutics Recent Developments
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Placental Stem Cell Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Placental Stem Cell Therapy Market Share by Type: 2022 VS 2029
Figure 3. Hematologic Malignancies and Disorders Features
Figure 4. Congenital Immunodeficiency Disorders Features
Figure 5. Metabolic Disorders Features
Figure 6. Neurological Disorders Features
Figure 7. Others Features
Figure 8. Global Placental Stem Cell Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Placental Stem Cell Therapy Market Share by Application: 2022 VS 2029
Figure 10. Hospitals and Specialty Clinics Case Studies
Figure 11. Clinical Research Organizations Case Studies
Figure 12. Research Institutes and Academies Case Studies
Figure 13. Others Case Studies
Figure 14. Placental Stem Cell Therapy Report Years Considered
Figure 15. Global Placental Stem Cell Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Placental Stem Cell Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Placental Stem Cell Therapy Market Share by Region: 2022 VS 2029
Figure 18. Global Placental Stem Cell Therapy Market Share by Players in 2022
Figure 19. Global Top Placental Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Placental Stem Cell Therapy as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Placental Stem Cell Therapy Revenue in 2022
Figure 21. North America Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Placental Stem Cell Therapy Market Share by Type (2018-2029)
Figure 23. North America Placental Stem Cell Therapy Market Share by Application (2018-2029)
Figure 24. North America Placental Stem Cell Therapy Market Share by Country (2018-2029)
Figure 25. United States Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Placental Stem Cell Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 28. Europe Placental Stem Cell Therapy Market Share by Type (2018-2029)
Figure 29. Europe Placental Stem Cell Therapy Market Share by Application (2018-2029)
Figure 30. Europe Placental Stem Cell Therapy Market Share by Country (2018-2029)
Figure 31. Germany Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. France Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. U.K. Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Italy Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Russia Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Nordic Countries Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. China Placental Stem Cell Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 38. China Placental Stem Cell Therapy Market Share by Type (2018-2029)
Figure 39. China Placental Stem Cell Therapy Market Share by Application (2018-2029)
Figure 40. Asia Placental Stem Cell Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 41. Asia Placental Stem Cell Therapy Market Share by Type (2018-2029)
Figure 42. Asia Placental Stem Cell Therapy Market Share by Application (2018-2029)
Figure 43. Asia Placental Stem Cell Therapy Market Share by Region (2018-2029)
Figure 44. Japan Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. South Korea Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. China Taiwan Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Southeast Asia Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. India Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Australia Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Placental Stem Cell Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Placental Stem Cell Therapy Market Share by Type (2018-2029)
Figure 52. Middle East, Africa, and Latin America Placental Stem Cell Therapy Market Share by Application (2018-2029)
Figure 53. Middle East, Africa, and Latin America Placental Stem Cell Therapy Market Share by Country (2018-2029)
Figure 54. Brazil Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Mexico Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Turkey Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Israel Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. GCC Countries Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 60. Lifebank Stem Cell Banking Revenue Growth Rate in Placental Stem Cell Therapy Business (2018-2023)
Figure 61. Cynata Revenue Growth Rate in Placental Stem Cell Therapy Business (2018-2023)
Figure 62. Celularity Revenue Growth Rate in Placental Stem Cell Therapy Business (2018-2023)
Figure 63. Athersys Revenue Growth Rate in Placental Stem Cell Therapy Business (2018-2023)
Figure 64. Americord Registry Revenue Growth Rate in Placental Stem Cell Therapy Business (2018-2023)
Figure 65. ReNeuron Group Revenue Growth Rate in Placental Stem Cell Therapy Business (2018-2023)
Figure 66. ReeLabs Revenue Growth Rate in Placental Stem Cell Therapy Business (2018-2023)
Figure 67. Mesoblast Revenue Growth Rate in Placental Stem Cell Therapy Business (2018-2023)
Figure 68. Pluristem Therapeutics Revenue Growth Rate in Placental Stem Cell Therapy Business (2018-2023)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed


More Publications